Proatherogenic sialidases and desialylated lipoproteins: 35 years of research and current state from bench to bedside
المؤلف | Mezentsev, Alexandre |
المؤلف | Bezsonov, Evgeny |
المؤلف | Kashirskikh, Dmitry |
المؤلف | Baig, Mirza S. |
المؤلف | Eid, Ali H. |
المؤلف | Orekhov, Alexander |
تاريخ الإتاحة | 2023-07-31T11:37:21Z |
تاريخ النشر | 2021-05-25 |
اسم المنشور | Biomedicines |
المعرّف | http://dx.doi.org/10.3390/biomedicines9060600 |
الاقتباس | Mezentsev, A., Bezsonov, E., Kashirskikh, D., Baig, M. S., Eid, A. H., & Orekhov, A. (2021). Proatherogenic sialidases and desialylated lipoproteins: 35 years of research and current state from bench to bedside. Biomedicines, 9(6), 600. |
الملخص | This review summarizes the main achievements in basic and clinical research of atheroscle-rosis. Focusing on desialylation as the first and the most important reaction of proatherogenic pathological cascade, we speak of how desialylation increases the atherogenic properties of low density lipoproteins and decreases the anti-atherogenic properties of high density lipoproteins. The separate sections of this paper are devoted to immunogenicity of lipoproteins, the enzymes contribut-ing to their desialylation and animal models of atherosclerosis. In addition, we evaluate the available experimental and diagnostic protocols that can be used to develop new therapeutic approaches for atherosclerosis. |
راعي المشروع | This research was funded by the Russian Science Foundation, grant number 18-15-00254. |
اللغة | en |
الناشر | Multidisciplinary Digital Publishing Institute (MDPI) |
الموضوع | Animal models of atherosclerosis Anti-LDL antibodies Apolipoproteins Atherogenesis Desialylation Diagnostics of atherosclerosis HDL LDL Sialidase Trans-sialidase Treatment options for atherosclerosis |
النوع | Article |
رقم العدد | 6 |
رقم المجلد | 9 |
ESSN | 2227-9059 |
الملفات في هذه التسجيلة
هذه التسجيلة تظهر في المجموعات التالية
-
أبحاث الطب [1382 items ]